Display options
Cite
Fukutomi T, Inoue R, Ushijima T, et al. Bilateral Breast Cancer in a Patient with a Strong Family History of Cancer: Analysis of p53 Germ Line Mutations. Breast Cancer. 1994;1(2):151-155doi: 10.1007/BF02967046.
Fukutomi, T., Inoue, R., Ushijima, T., Tsuda, H., & Adachi, I. (1994). Bilateral Breast Cancer in a Patient with a Strong Family History of Cancer: Analysis of p53 Germ Line Mutations. Breast cancer (Tokyo, Japan), 1(2), 151-155. https://doi.org/10.1007/BF02967046
Fukutomi, et al. "Bilateral Breast Cancer in a Patient with a Strong Family History of Cancer: Analysis of p53 Germ Line Mutations." Breast cancer (Tokyo, Japan) vol. 1,2 (1994): 151-155. doi: https://doi.org/10.1007/BF02967046
Fukutomi T, Inoue R, Ushijima T, Tsuda H, Adachi I. Bilateral Breast Cancer in a Patient with a Strong Family History of Cancer: Analysis of p53 Germ Line Mutations. Breast Cancer. 1994 Dec 30;1(2):151-155. doi: 10.1007/BF02967046. PMID: 11091524.
Copy Download .nbib Format: NLM
Share it on

Breast Cancer. 1994 Dec 30;1(2):151-155. doi: 10.1007/BF02967046.

Bilateral Breast Cancer in a Patient with a Strong Family History of Cancer: Analysis of p53 Germ Line Mutations.

Breast cancer (Tokyo, Japan)

Fukutomi, Inoue, Ushijima, Tsuda, Adachi

Affiliations

  1. Departments of Surgery, National Cancer Center Hospital, 5-1-1 Tsukiji, DChuo-ku, Tokyo 104, Japan.

PMID: 11091524 DOI: 10.1007/BF02967046

Abstract

We report a case of bilateral breast carcinoma in a patient with a strong family history, including 4 cases of breast carcinoma, 1 case of prostate carcinoma (father), 1 case of hepatocellular carcinoma (mother), 2 cases of gastric carcinoma, 1 case of lung carcinoma, and 1 case of lingual carcinoma, in second degree relatives, together with analysis of germ line p53 mutations. The patient was a 51-year-old female who had undergone mastectomy 9 years previously for an invasive ductal carcinoma of the right breast. Lymph nodes were free of metastases and the tumor had negative estrogen receptor (ER) status. Bone and lung metastases developed 18 months after surgery, and had been well controlled with chemoendocrine therapy. She subsequently underwent a modified radical mastectomy for carcinoma in the contralateral breast. This was an invasive lobular carcinoma with negative lymph node metastasis, negative p53 immunoreaction, negative c-erbB-2 protein and positive ER status. In this breast-prostate carcinoma-type cancer family there was a high incidence of breast carcinoma; the father, who had prostate carcinoma, was possibly a carrier of a breast carcinoma susceptible gene. We have however detected to p53 germ line mutations in the lymphocytes DNA of the patient and her niece. The accumulation of cancers in this family line remains to be elucidated further using other genetic markers.

References

  1. Genomics. 1989 Nov;5(4):874-9 - PubMed
  2. Hum Genet. 1992 Jun;89(4):381-3 - PubMed
  3. Jpn J Cancer Res. 1990 Apr;81(4):327-32 - PubMed
  4. Surg Today. 1993;23(10):849-54 - PubMed
  5. Ann Intern Med. 1969 Oct;71(4):747-52 - PubMed
  6. Science. 1990 Nov 30;250(4985):1233-8 - PubMed
  7. Cancer Res. 1992 Jun 1;52(11):3234-6 - PubMed
  8. Am J Hum Genet. 1993 Apr;52(4):711-7 - PubMed
  9. Breast Cancer Res Treat. 1993 Nov;28(2):107-13 - PubMed
  10. Science. 1990 Dec 21;250(4988):1684-9 - PubMed
  11. Oncogene. 1992 May;7(5):1043-6 - PubMed
  12. Jpn J Cancer Res. 1991 Jul;82(7):835-40 - PubMed

Publication Types